Bicalutamide Tablets - Uses, Dosage and Side Effects

Bicalutamide is an oral non-steroidal anti-androgen used in the treatment of advanced prostate cancer (D2 metastatic prostate cancer) and hirsutism. Bicalutamide (Generic Casodex ) was first launched in 1995 as a combination treatment for advanced prostate cancer and subsequently launched as monotherapy for the treatment of earlier stages of the disease.

Uses of Bicalutamide Tablets (Generic Casodex)

Bicalutamide is used for the treatment of stage D2 metastatic prostate cancer in combination with a luteinizing hormone-releasing hormone analogue or as a monotherapy.

Bicalutamide Tablets (Generic Casodex) - Contraindications and Warnings

Bicalutamide is contraindicated in females and children and must not be given to any patient who has shown a hypersensitivity reaction to its use.
Bicalutamide is a teratogen and must not be handled by females who are or may become pregnant. Bicalutamide is known to cause fetal harm.

Side Effects of Bicalutamide Tablets (Generic Casodex)

Side Effects of Bicalutamide Tablets include reproductive system and breast disorders, breast tenderness, gynaecomastia, hot flushes, gastrointestinal disorders, diarrhoea, nausea, hepatic changes (elevated levels of transaminases, jaundice), asthenia and pruritus.

Bicalutamide Tablets (Generic Casodex ) - Dosage

The recommended dosage of Generic Casodex Tablets (Bicalutamide) is 50 mg once daily, either in the morning or evening, in combination with a luteinizing hormone-releasing hormone analogue.

Bicalutamide Tablets - Availability And Packaging

Bicalutamide is available as Generic Casodex Tablets which is packaged as tablets of 50 mg. Bicalutamide is marketed by AstraZeneca with the brand names Casodex and Cosudex. It is also available as Calutide, Kalumid

Additional Information

Prescribing Information

Considerable portions of the text here is from and is reproduced here under the Creative Commons Attribution-ShareAlike License